The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Dexcom (Nasdaq:DXCM) today posted first-quarter financial results that came in ahead of the Wall Street forecast.
Zacks Investment Research on MSN
Why DexCom (DXCM) is a top value stock for the long term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...
Zacks Investment Research on MSN
DexCom Stock Up on Q1 Earnings & Revenues Beat, Margins Rise
DexCom, Inc. DXCM reported first-quarter 2026 adjusted earnings per share (EPS) of 56 cents, which beat the Zacks Consensus ...
Shares of DexCom Inc. DXCM shed 1.12% to $62.70 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.41% to 7,108.40 and Dow ...
DexCom's growth rate has been accelerating for multiple quarters, and recently came in at around 22%. A rise in GLP-1 drugs has some investors concerned that DexCom's growth opportunities may be ...
Medical device maker Dexcom on Thursday reiterated its full-year revenue forecast after beating Wall Street estimates for ...
(DXCM) on Thursday reported first-quarter earnings of $199.5 million. The San Diego-based company said it had profit of 51 cents per share. Earnings, adjusted for amortization costs and pretax ...
Shares of DexCom Inc. DXCM shed 1.80% to $61.57 Friday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.80% to 7,165.08 and the Dow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results